Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McInnes

Showing results (241-250 of 537) with videos related to

Pageof 54
Sort By:
The Journal of Rheumatology|June 17, 2019
Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing SpondylitisAtul Deodhar, Dafna D Gladman, Iain B McInnes, et al.
RMD Open|January 4, 2023
JAK inhibitors disrupt T cell-induced proinflammatory macrophage activationMukanthu H Nyirenda, Jagtar Singh Nijjar, Marina Frleta-Gilchrist, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2010
Abatacept limits breach of self-tolerance in a murine model of arthritis via effects on the generation of T follicular helper cellsAndrew M Platt, Vivienne B Gibson, Agapitos Patakas, et al.
Clinical Immunology (Orlando, Fla.)|June 19, 2023
Distinct innate and adaptive immunity phenotypic profile at the circulating single-cell level in Psoriatic ArthritisGeorge E Fragoulis, Eleni-Kyriaki Vetsika, Maria Kyriakidi, et al.
Arthritis Research & Therapy|September 24, 2004
Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrateMichele Bombardieri, Francesca Barone, Valerio Pittoni, et al.
The Lancet. Rheumatology|February 21, 2024
Gout and incidence of 12 cardiovascular diseases: a case-control study including 152 663 individuals with gout and 709 981 matched controlsLyn D Ferguson, Geert Molenberghs, Geert Verbeke, et al.
Annals of the Rheumatic Diseases|February 24, 2011
Phosphodiesterase 4 (PDE4) regulation of proinflammatory cytokine and chemokine release from rheumatoid synovial membraneAnne Crilly, Susan E Robertson, James H Reilly, et al.
Rheumatology and Therapy|September 18, 2021
Articular and Extra-Articular Benefits in ACR20 Non-responders at Week 104 Treated With Apremilast: Pooled Analysis of Three Randomized Controlled TrialsPhilip J Mease, Dafna D Gladman, Arthur Kavanaugh, et al.
The Lancet. Respiratory Medicine|June 20, 2020
Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunitiesPuja Mehta, Joanna C Porter, Jessica J Manson, et al.
Nature Medicine|December 2, 1999
Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoidsJ D Young, A J Lawrence, A G MacLean, et al.
Pageof 54

Showing results (241-250 of 537) with videos related to

Sort By:
Pageof 54
The Journal of Rheumatology|June 17, 2019
Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing SpondylitisAtul Deodhar, Dafna D Gladman, Iain B McInnes, et al.
RMD Open|January 4, 2023
JAK inhibitors disrupt T cell-induced proinflammatory macrophage activationMukanthu H Nyirenda, Jagtar Singh Nijjar, Marina Frleta-Gilchrist, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2010
Abatacept limits breach of self-tolerance in a murine model of arthritis via effects on the generation of T follicular helper cellsAndrew M Platt, Vivienne B Gibson, Agapitos Patakas, et al.
Clinical Immunology (Orlando, Fla.)|June 19, 2023
Distinct innate and adaptive immunity phenotypic profile at the circulating single-cell level in Psoriatic ArthritisGeorge E Fragoulis, Eleni-Kyriaki Vetsika, Maria Kyriakidi, et al.
Arthritis Research & Therapy|September 24, 2004
Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrateMichele Bombardieri, Francesca Barone, Valerio Pittoni, et al.
The Lancet. Rheumatology|February 21, 2024
Gout and incidence of 12 cardiovascular diseases: a case-control study including 152 663 individuals with gout and 709 981 matched controlsLyn D Ferguson, Geert Molenberghs, Geert Verbeke, et al.
Annals of the Rheumatic Diseases|February 24, 2011
Phosphodiesterase 4 (PDE4) regulation of proinflammatory cytokine and chemokine release from rheumatoid synovial membraneAnne Crilly, Susan E Robertson, James H Reilly, et al.
Rheumatology and Therapy|September 18, 2021
Articular and Extra-Articular Benefits in ACR20 Non-responders at Week 104 Treated With Apremilast: Pooled Analysis of Three Randomized Controlled TrialsPhilip J Mease, Dafna D Gladman, Arthur Kavanaugh, et al.
The Lancet. Respiratory Medicine|June 20, 2020
Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunitiesPuja Mehta, Joanna C Porter, Jessica J Manson, et al.
Nature Medicine|December 2, 1999
Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoidsJ D Young, A J Lawrence, A G MacLean, et al.
Pageof 54